Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | HSP90AB1 | P08238 | 7/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.43 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | PNLIP | P16233 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2821382 | 0.93 | ALOX5 (0.47) | ALOX5HSP90AB1HDAC1TBXAS1POLB | |
| SCHEMBL2819631 | 0.91 | POLB (0.51) | ALOX5HSP90AB1HDAC1TBXAS1POLB | |
| SCHEMBL2821360 | 0.91 | ALOX5 (0.56) | ALOX5HSP90AB1POLBL3MBTL1MGAM | |
| SCHEMBL2821734 | 0.91 | HDAC1 (0.49) | ALOX5HSP90AB1HDAC1HSP90AA1TBXAS1 | |
| SCHEMBL2820647 | 0.91 | ALOX5 (0.48) | ALOX5HSP90AB1TBXAS1POLBL3MBTL1 | |
| SCHEMBL2821229 | 0.91 | ALOX5 (0.48) | ALOX5HSP90AB1HDAC1TBXAS1POLB | |
| SCHEMBL2825948 | 0.90 | HDAC1 (0.44) | ALOX5HSP90AB1HDAC1HSP90AA1POLB | |
| SCHEMBL2819724 | 0.89 | ALOX5 (0.43) | ALOX5HSP90AB1HDAC1TBXAS1POLB | |
| SCHEMBL2819127 | 0.88 | ALOX5 (0.46) | ALOX5HSP90AB1TBXAS1POLBL3MBTL1 | |
| SCHEMBL2821451 | 0.85 | HDAC1 (0.44) | HSP90AB1HDAC1HSP90AA1TBXAS1MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100184815-A1 | AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA | MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC | 2010-07-22 | — | — | US | claimed |
| WO-2010071813-A1 | AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-α | ARYX THERAPEUTICS, INC. (US) | 2010-06-24 | — | — | WO | claimed |
| US-20100184815-A1 | AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA | MPM ASSET MANAGEMENT INVESTORS 2002 BVIII LLC | 2010-07-22 | — | — | US | disclosed |
| WO-2010071813-A1 | AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-α | ARYX THERAPEUTICS, INC. (US) | 2010-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184815-A1 | AGONISTS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-ALPHA | PPARA, PPARD, PPARG | ALOX5 570/4885HSP90AB1 937/4885HDAC1 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.